Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOS) 2016-2026

LONDON, October 6, 2016 /PRNewswire/ --

North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing

In its updated report, visiongain provides revenues to 2026 for the world pharmaceutical contract manufacturing organisations (CMO) market.

This report also analyses leading companies in pharmaceutical contract manufacturing. The demand for outsourced drug production has grown rapidly in the past 10 years. The world market for pharma contract manufacturing was worth $61.6bn in 2015, having grown by more than 6% from 2014.

The new study predicts strong growth in that industry's revenue, reaching $84.0bn worldwide in 2020, with further expansion expected.

Our 317-page report provides 185 tables, 110 figures and analysis of 30 leading companies.

The content of each profile differs, depending on the organisation. In general, though, a profile gives you the following information:
• Overview of the company's contract manufacturing services and operations
• Analysis of recent financial performance - annual revenue for CMO services, including some data on operating profit and margins
• Assessment of developments - activities, acquisitions, production capacity, deals, new service offerings and collaborations
• SWOT analysis - a firm's strengths and weaknesses, as well as opportunities and threats to manufacturing sales growth from 2015 onwards
• Forecasting of pharmaceutical manufacturing revenue to 2026, as well as projected operating profit and margin for some companies.

To see a report overview please email Sara Peerun on [email protected]

Leading Pharmaceutical Contract Manufacturing Organisations profiled in this report:
• Catalent
• Patheon
• Baxter
• AbbVie
• Pfizer
• Lonza
• Evonik Degussa
• Royal DSM
• Boehringer Ingelheim
• Fareva
• Aenova
• Famar
• Vetter
• Almac
• Delpharm
• Siegfried
• Corden
• Recipharm
• Aesica
• Nipro
• Daito
• Teva API
• Esteve Quimica
• Euticals
• Zhejiang Hisun Pharmaceuticals
• Zhejiang Huahai Pharmaceuticals
• Shandong Xinhua Pharmaceuticals
• Aurobindo Pharma
• Divis Laboratories
• Dr. Reddy's Laboratories 

To see a report overview please email Sara Peerun on [email protected]

To request a report overview of this report please emails Sara Peerun at [email protected] or call Tel: +44 (0) 20 7336 6100

Or click on https://www.visiongain.com/Report/1735/Pharma-Leader-Series-Top-30-Pharmaceutical-Contract-Manufacturing-Organisations-(CMOs)-2016-2026

Organisations Mentioned in this Report 

Abbott Laboratories

Abic

AbbVie    

Actavis

Adamas Pharmaceuticals

Aegerion

Aenova Group

Aesica Pharmaceuticals

Agence Nationale de sécurité du Médicament et des produits de santé (ANSM)

Agência Nacional de Vigilância Sanitária (ANVISA)

Agennix

Aguettant

AlgoNomics

Alliance Medical Products

Almac Group

Alpharma

Amgen

AMYRA Biotech

Andeno

Apexigen

Aptuit

Archimica

Arecor

ArGEN-X

Astellas

AstraZeneca

Athera Biotechnologies

Aurobindo Pharma

Avalanche Biotechnologies

Banner Life Sciences

BaroFold

Barr-Pliva

BASF

Baxter BioPharma Solutions

Bayer

BC Partners

Becton and Dickinson (BD)

Beijing Double-Crane Pharmaceutical

Bentley

Biocraft

Biogal

Biomedical Advanced Research and Development Authority  (BARDA)

Bionomics

Biotest

BioWa

Boehringer Ingelheim

Bridgepoint Capital

Bristol-Myers Squibb

Britest

Canyon

Carbogen Amcis

Cardinal Health

Catalent

Celladon

Celldex Therapeutics

Celsion

CEVEC Pharmaceuticals

Chemtrix BV

China National Pharmaceutical Group (SInopharm)

Chirotech

Circadian Technologies

Cleveland BioLabs

Cobra Biomanufacturing

Companies House

CordenPharma

Corvette Pharmaceutical Services

Daiichi Sankyo

Daito

DecImmune Therapeutics

Delmas Perfusion

Delpharm

Divis Laboratories

DPx Holdings

Dr. Reddy's Laboratories

Dragenopharm Apotheker Püschl and Swiss Caps

Eclipse Therapeutics

Eindhoven University of Technology

Eisai

Eli Lilly

EmulTech

Esteve Química

Euro Vital Pharma

European Medicines Agency (EMA)

Euticals

Evonik Degussa

Excella

Exelixis

Famar

Fareva

Farmaprojects

Frazier Healthcare

Fuyang Xinghai Investment

Genentech

Générique Même Médicament (GEMME)

Genzyme

GSK

Corixa

Haupt Pharma

Health Canada

Hejiang Jiang Yuan Tang Biotechnology

Human Genome Sciences

ICI

Immune Pharmaceuticals

Immunomedics

Index Ventures

Indoco Remedies

Intellect Neurosciences

International Chemical Investors Group

Ivax API

Japanese Ministry of Health Labor and Welfare (MHWL)

Japanese Pharmaceutical and Medical Devices Agency (PMDA)

JK Pharmaceutical

JLL Partners

Johnson & Johnson (J&J)

Kadmon

Laboratoires Besins

Lanxess Corporation

LBO Italia Investimenti s.r.l

Lonza

Marinopoulos Group.

MedImmune

Merck KGaA

Merck Serono

Mesoblast

Molecular Partners

Moody's Corporation

Mylan

NIH CRM

Nipro Corporation

Novartis

Novasep

Novozymes

NPS

OctoPlus

OncoMed Pharmaceuticals

Opthea

Osiris Therapeutics

Otsuka Pharmaceutical

Pantec

Patheon

Perrigo

PFC

Pfizer

Pharmacia

Pharmacyclis

Pharmintraco

Piramal

Plantex

Poli Industria Chimica

Progenics Pharmaceuticals

Prosintex

R5 Pharmaceuticals

RAG AG

Ranbaxy Labs

Recipharm

Regeneus

Relthy Laboratórios

Relypsa

Respirics

Rexim

Roche

Royal DSM

Sandoz

Sanofi

Sanquin Blood Supply foundation

Sanwa Kagaku Kenkyusho

Schering

ScinoPharm

Seattle Genetics

Sentry BioPharma Services

Servier

Shandong Tianda Biological Pharmaceutica

Shandong Xinhua Pharmaceutical

Shanghai Pharmaceutical

ShangPharma

Shire

Sicor

Siegfried

Sigmar Italia

Silverfleet Capital

Sinochem

SkyePharma

Solvay

Sun Pharma

Supernus Pharmaceuticals

SurModics

Swedbank

Swedish Orphan Biovitrium AB (Sobi)

Synkem

Syntex

Synthon

Takeda

Temmler Group

Tessenderlo Group

Teva Pharmaceutical Industries

Theramax

Tianjin Tianyo Pharmaceuticals

Tianma Tianji

Tunitas Therapeutics

UCB

UK Health and Safety Executive

UK Medicines and Healthcare Products Regulatory Agency (MHRA)

UMN Pharma

UniQure

University College London (UCL)

University of Bradford

University of Durham

University of Leeds

US Food and Drug Administration (FDA)

Vetter Pharma

Vidara

ViroPharma

Vivante GMP Solutions

VTU Technology

West Pharma

Wockhardt

XOMA

Yiwu Huayi Investment

Zhangjiang Biotech & Pharmaceutical Base Company

Zhejiang Hisun Pharmaceutical

Zhejiang Huahai Pharmaceuticals

To see a report overview please email Sara Peerun on [email protected]

SOURCE Visiongain Ltd